Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

ClinicalTrials.gov ID: NCT00414661

Public ClinicalTrials.gov record NCT00414661. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Observational Study To Evaluate Long-Term Safety And Functional Status Of Subjects With Rheumatoid Arthritis Previously Enrolled In Studies Of CP-690,550

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to follow the health of subjects who have previously been enrolled in studies of CP-690,550 for treatment of their rheumatoid arthritis. Subjects are only eligible for this study after they have completed all participation in other studies of CP-690,550.

Study identification

NCT ID
NCT00414661
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Pfizer
Industry
Enrollment
162 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2007 (Type not available)
Primary completion
Feb 2012 (Actual)
Completion
Feb 2012 (Actual)
Last update posted
Jan 1, 2013

2007 – 2012

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
18
Facility City State ZIP Site status
Pfizer Investigational Site Gilbert Arizona 85234 —
Pfizer Investigational Site Tucson Arizona 85704 —
Pfizer Investigational Site Palo Alto California 94304 —
Pfizer Investigational Site San Diego California 92108 —
Pfizer Investigational Site Stanford California 94305 —
Pfizer Investigational Site Upland California 91786 —
Pfizer Investigational Site Ocala Florida 34474 —
Pfizer Investigational Site Orlando Florida 32804 —
Pfizer Investigational Site Sarasota Florida 34233 —
Pfizer Investigational Site Tampa Florida 33613 —
Pfizer Investigational Site Tampa Florida 33614 —
Pfizer Investigational Site Venice Florida 34292 —
Pfizer Investigational Site Rockford Illinois 61107 —
Pfizer Investigational Site Lincoln Nebraska 68516 —
Pfizer Investigational Site Albany New York 12206-1043 —
Pfizer Investigational Site Hickory North Carolina 28601 —
Pfizer Investigational Site Hickory North Carolina 28602 —
Pfizer Investigational Site Wyomissing Pennsylvania 19610 —
Pfizer Investigational Site Mesquite Texas 75150 —
Pfizer Investigational Site Tacoma Washington 98405-2308 —
Pfizer Investigational Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00414661, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 1, 2013 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00414661 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →